Value Partners’s AbbVie ABBV Stock Holding History

Value Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$489K	Sell	7,900 -1,638	-17%	-$99.8K	0.31%	19
2016 Q1	$545K	Buy	+9,538	New	+$532K	0.49%	15
2015 Q1	–	Sell	-44,636	Closed	-$2.92M	–	9
2014 Q4	$2.92M	Hold	44,636	–	–	4.76%	6
2014 Q3	$2.58M	Sell	44,636 -17,139	-28%	-$952K	4.53%	11
2014 Q2	$3.49M	Sell	61,775 -792	-1%	-$41.5K	4.91%	6
2014 Q1	$3.22M	Hold	62,567	–	–	3.71%	8
2013 Q4	$3.3M	Buy	+62,567	New	+$3.08M	2.47%	9

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Value Partners's ABBV Position: Q2 2016 in Review

Value Partners reduced its AbbVie (ABBV) stake by 17% in Q2 2016, selling an estimated $99.8K and leaving 7,900 shares worth $489K. The position accounts for 0.31% of the portfolio, ranked #19.

Value Partners first reported a position in ABBV in Q4 2013 and has held it in 7 quarters since. The position peaked at $3.49M in Q2 2014. 1,634 funds tracked by Wall St. Rank hold ABBV as of Q2 2016.

Value Partners held 7,900 shares of AbbVie worth $489K as of Q2 2016.
Value Partners sold 1,638 AbbVie shares in Q2 2016, an estimated $99.8K.
AbbVie made up 0.31% of Value Partners's portfolio in Q2 2016, its #19 holding.
Value Partners first reported a position in AbbVie in Q4 2013 and has held it in 7 quarters since.
Value Partners's AbbVie position peaked at $3.49M in Q2 2014.
1,634 funds tracked by Wall St. Rank held AbbVie as of Q2 2016.

Based on Value Partners's 13F filing for Q2 2016, filed 12 Aug 2016.